Table 1.
Cellular Response | Cell Type(s) | Pathology | References |
---|---|---|---|
Proliferation | Human endothelial cells | In vitro | [44] |
Human smooth muscle cells | In vitro | [44] | |
Rat endothelial cells | Angiogenesis in rat corneas | [44] | |
Mice endothelial cells | Arthritis | [45] | |
Mice smooth muscle cells | Restenosis | [21] | |
Post-natal rat cardiomyocytes | In vitro | [31] | |
Rat cardiac fibroblasts | In vitro | [32] | |
Migration | Human endothelial cells | In vitro | [33,46] |
Rat aortic smooth muscle cells | In vitro | [35] | |
Mice smooth muscle cells | In vitro | [21] | |
Survival | Cardiomyocyte cell line H9C2 | In vitro/rat ischemia/reperfusion model |
[47] |
Differentiation | Mice Smooth muscle cells. (Contractile-Synthetic) |
In vitro/In vivo in diabetes- induced atherosclerosis in ApoE-/- mice | [35] |
Human endothelial cells (Endothelial activation/Expression of Adhesion molecules) |
In vitro | [46] | |
Mice endothelial cells (Endothelial activation/Expression of Adhesion molecules) |
In vivo in diabetes induced atherosclerosis in ApoE-/- mice | [35] | |
Bone marrow-derived macrophages. (Lipid uptake/Foam cells formation) | In vitro | [48] | |
Human vascular smooth muscle cells (Osteogenic transition/Calcification) |
In vitro | [49] | |
Human aortic vascular smooth muscle cells (Prothrombotic phenotype/Expression of Prothrombotic factors) | In vitro | [50] | |
Adult rat cardiomyocytes (Hypertrophy) | In vitro | [51] |